Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement

被引:528
|
作者
Moarefi, I
LaFevreBernt, M
Sicheri, F
Huse, M
Lee, CH
Kuriyan, J
Miller, WT
机构
[1] SUNY STONY BROOK, SCH MED, DEPT PHYSIOL & BIOPHYS, STONY BROOK, NY 11794 USA
[2] ROCKEFELLER UNIV, MOL BIOPHYS LAB, NEW YORK, NY 10021 USA
[3] ROCKEFELLER UNIV, HOWARD HUGHES MED INST, NEW YORK, NY 10021 USA
关键词
D O I
10.1038/385650a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The protein Hck is a member of the Src family of non-receptor tyrosine kinases which is preferentially expressed in haematopoietic cells of the myeloid and B-lymphoid lineages(1,2). Src kinases are inhibited by tyrosine-phosphorylation at a carboxy-terminal site(3-9). The SH2 domains of these enzymes play an essential role in this regulation by binding to the tyrosine-phosphorylated tail(8-11). The crystal structure of the downregulated form of Hck has been determined(12) and reveals that the SH2 domain regulates enzymatic activity indirectly; intramolecular interactions between the SH3 and catalytic domains appear to stabilize an inactive form of the kinase, Here we compare the roles of the SH2 and SH3 domains in modulating the activity of Hck in an investigation of the C-terminally phosphorylated form of the enzyme, We show that addition of the HIV-1 Nef protein, which is a high-affinity ligand for the Hck SH3 domain, to either the downregulated or activated form of Hck causes a large increase in Hck catalytic activity, The intact SH3-binding motif in Nef is crucial for Hck activation. Our results indicate that binding of the Hck SH3 domain by Nef causes a more marked activation of the enzyme than does binding of the SH2 domain, suggesting a new mechanism for regulation of the activity of tyrosine kinases.
引用
收藏
页码:650 / 653
页数:4
相关论文
共 50 条
  • [1] Activation of the Sire-family tyrosine kinase Hck by SH3 domain displacement
    Ismail Moarefi
    Michelle LaFevre-Bernt
    Frank Sicheri
    Morgan Huse
    Chi-Hon Lee
    John Kuriyan
    W. Todd Miller
    Nature, 1997, 385 : 650 - 653
  • [2] Differential Sensitivity of Src-Family Kinases to Activation by SH3 Domain Displacement
    Moroco, Jamie A.
    Craigo, Jodi K.
    Iacob, Roxana E.
    Wales, Thomas E.
    Engen, John R.
    Smithgall, Thomas E.
    PLOS ONE, 2014, 9 (08):
  • [3] Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain
    Schreiner, SJ
    Schiavone, AP
    Smithgall, TE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (47) : 45680 - 45687
  • [4] ACTIVATION OF PHOSPHATIDYLINOSITOL-3' KINASE BY SRC-FAMILY KINASE SH3 BINDING TO THE P85 SUBUNIT
    PLEIMAN, CM
    HERTZ, WM
    CAMBIER, JC
    SCIENCE, 1994, 263 (5153) : 1609 - 1612
  • [5] Pathway of Src-family tyrosine kinase activation and inactivation
    Ozkirimli, E
    Post, CB
    BIOPHYSICAL JOURNAL, 2004, 86 (01) : 302A - 303A
  • [6] Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma
    Hildo C. Lantermans
    Marthe Minderman
    Annemieke Kuil
    Marie-José Kersten
    Steven T. Pals
    Marcel Spaargaren
    Leukemia, 2021, 35 : 881 - 886
  • [7] Activation of the Src family kinase Hck without SH3-linker release
    Lerner, EC
    Trible, RP
    Schiavone, AP
    Hochrein, JM
    Engen, JR
    Smithgall, TE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (49) : 40832 - 40837
  • [8] Identification of tyrosine residues on ELMO1 that are phosphorylated by the Src-family kinase Hck
    Yokoyama, N
    deBakker, CD
    Zappacosta, F
    Huddleston, MJ
    Annan, RS
    Ravichandran, KS
    Miller, WT
    BIOCHEMISTRY, 2005, 44 (24) : 8841 - 8849
  • [9] Interaction with the Src Homology (SH3-SH2) Region of the Src-family Kinase Hck Structures the HIV-1 Nef Dimer for Kinase Activation and Effector Recruitment
    Alvarado, John Jeff
    Tarafdar, Sreya
    Yeh, Joanne I.
    Smithgall, Thomas E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (41) : 28539 - 28553
  • [10] Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma
    Lantermans, Hildo C.
    Minderman, Marthe
    Kuil, Annemieke
    Kersten, Marie-Jose
    Pals, Steven T.
    Spaargaren, Marcel
    LEUKEMIA, 2021, 35 (03) : 881 - 886